AVBC vs BMY · rev $130.6M vs P/E 17, rev $24.46B
Avidia Bancorp, Inc. (AVBC) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Avidia Bancorp, Inc. (AVBC) is a banks - regional company listed on US.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Latest reported AVBC revenue for 2025-12-31 was $130.6M. Net income was -$3.3M. Revenue was up 5.5% from 2024-12-31 to 2025-12-31. AVBC currently screens at market cap $0.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
AVBC currently screens at market cap $0. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the AVBC and BMY stock pages for the full models.
Not investment advice.